Type 1 VWD |
• ∼65% of index cases have candidate VWF mutations |
|
• ∼70% of VWF variants are missense substitutions influencing VWF trafficking, storage, secretion, and clearance |
|
• Additional transcription and splicing VWF mutations |
Type 2A VWD |
• Missense variants in D1/D2/D′D3 assemblies, A2 and CTCK domains |
|
• Interference with HMW multimer formation, storage, and secretion |
|
• Enhanced ADAMTS13 proteolysis |
Type 2B VWD |
• Missense variants in A1 domain |
|
• Enhanced binding to GPIbα
|
Type 2M VWD |
• Missense variants in A1 and A3 domains |
|
• Reduced binding to GPIbα (A1 domain) or collagen (A3 domain) |
Type 2N VWD |
• Missense variants in D′D3 assembly |
|
• Reduced FVIII binding |
Type 3 VWD |
• VWF mutations found in 85%-90% of index cases |
|
• VWF deletions, nonsense, splice site, and missense mutations |